In a rat model of ischemic stroke, administration of the anti-C5 monoclonal antibody, specifically blocking the generation of C5a and C5b-9, reduced brain infarct volume and edema and improved neurological function at 24 hours after ischemia [270, 424]. This evidence concerns the gene C5AR1 and ischemia.